MedPath

The Effectiveness of Parassacral Transcutaneous Stimulation Compared to Tibial Transcutaneous Stimulation, Home Protocol and Behavioral Therapy in the Treatment of Female Hyperative Bladder: Randomized Clinical Trial

Not Applicable
Recruiting
Conditions
Urgent Urinary Incontinence
Women
Transcutaneous Electrical Nerve Stimulation
Bladder Hyperactive
Interventions
Device: parassacral transcutaneous electrostimulation
Registration Number
NCT04909047
Lead Sponsor
Centro de Atenção ao Assoalho Pélvico
Brief Summary

Introduction: The overactive bladder is a highly prevalent condition, which negatively impacts the quality of life and daily activities of women. Transcutaneous electrostimulation is currently a therapeutic alternative for urinary urgency symptoms. Although it can be applied to the sacral plexus or tibial nerve, the literature shows the effectiveness of these two modalities, in isolation, but there are few scientific studies that compare them as two therapeutic alternatives. Primary objective: to evaluate the efficacy between parascutaneous electrostimulation, tibial transcutaneous stimulation, and home protocol in the treatment of female overactive bladder. Methodology: This is a clinical trial, which will include women with a clinical complaint of overactive bladder, with or without urgency-incontinence, who will be randomized into 3 groups: transcutaneous parasacral electrostimulation (EETP), transcutaneous tibial electrostimulation (EETT) and a third group, home transcutaneous parasacral electrostimulation (EETPD), will consist of women who have financial difficulties or locomotion to attend the clinic.All groups, in the first session, will be guided to conduct behavioral therapy and will receive an educational booklet with guidelines. The equipment to be used will have a wave frequency of 10 Hz, a pulse width of 700 µs and a 20-minute session, with intensities according to the participant's tolerance. The intervention protocol of the EETP group is 30 sessions, three times a week, with an active electrode in the parasacral region. For EETT, 30 sessions will also be held, three times a week, with the electrode active in the tibial region. Participants will be captured at educational events held by the Pelvic Floor Service Center in Salvador and the metropolitan region. Participants will answer the basic anamnesis questionnaires, ICIQ-OAB, ROMA III criteria, Bristol scale, Hospital Anxiety and Depression Scale, Oswestry scale, Pittsburgh sleep quality index and Female Sexual Function Index. Then, the assessment of the bladder neck and the thickness of the bladder wall will be performed by 2D ultrasonography via suprapubic and intravaginal, following the assessment protocol described for the intervention groups. Primary outcomes: clinical improvement of symptoms, urinary frequency, episodes of urgent urinary incontinence, presence of adverse effects and constipation. Secondary outcomes: quality of life, sexual function, quality of sleep, anxiety and depression, muscle function (PERFECT and electromyography), lumbar-pelvic pain (pain intensity) and ultrasound. Participants will be followed for a minimum of 12 months to verify the long-term response, returning every 3 months. Expected results: The outpatient transcutaneous parasacral electrostimulation is expected to be superior when compared to the tibial transcutaneous electrostimulation in the resolution of the symptoms of the overactive female bladder.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
120
Inclusion Criteria
  • Women with symptoms of overactive bladder, aged 18 to 65 years.
Exclusion Criteria
  • Participants who have difficulty understanding the stages of the research, report cognitive deficit or psychiatric illness, patients with congenital orthopedic / neurological diseases, overactive bladder due to neurological impairment, presence of lower urinary tract infection, sensory deficit in the sacral or tibial region, diagnosis of chronic renal failure, patients with pacemakers and implantable cardioverter defibrillators and pregnant women.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Parasacral transcutaneous electrostimulation outpatientparassacral transcutaneous electrostimulationelectrostimulation device
home parasacral electrostimulationparassacral transcutaneous electrostimulationelectrostimulation device
transcutaneous tibial electrostimulation outpatientparassacral transcutaneous electrostimulationelectrostimulation device
Primary Outcome Measures
NameTimeMethod
Reduction of urinary leakage episodes90 days

Clinical improvement of symptoms of urinary leakage episodes analyzed by voiding diary, urofluxometry and International Consultation on Incontinence Questionnaire Overactive Bladder (ICIQ-OAB)

Reduction in urinary frequency90 days

Reduction in the number of daily urination analyzed by voiding diary , urofluxometry, 2 D ultrasonography and International Consultation on Incontinence Questionnaire Overactive Bladder (ICIQ-OAB)

Clinical improvement of constipation90 days

Effort in bowel movements, stool shape, number of weekly bowel movements analyzed by Rome, Bristol criterion and 2 D ultrasonography

Secondary Outcome Measures
NameTimeMethod
Quality of sleep90 days

Will be used the Pittsburgh sleep quality index (PSQI)

Measuring quality of life by questionnaire90 days

Will be used the King´s Health Questionnaire (KHQ)

Sexual function90 days

Will be used the questionnaire of Female Sexual Function (FSFI)

Muscle function90 days

Analyze through the PERFECT test and by electromyography

Anxiety and depression90 days

Scale of the Hospital Anxiety and Depression Scale (HADS)

Trial Locations

Locations (3)

Cebtro de Atebçao ao Assolaho Pévico- Escola Bahiana de Medicina e Saúde Pública

🇧🇷

Salvador, Bahia, Brazil

Centro de Atenção ao assoalho pélvico

🇧🇷

Salvador, Bahia, Brazil

Centro de Atenção ao Assoalho Pelvico

🇧🇷

Salvador, Ba, Brazil

© Copyright 2025. All Rights Reserved by MedPath